Physician profile
David L Phillips
NPI 1649538638
$2,593.23
in general payments reported to CMS, 2019-2025
18 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $410 · 2021: $212 · 2022: $229 · 2023: $648 · 2024: $352 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $805.67 | 2019-2025 | Clareon, Rocklatan, Argos |
| Allergan, INC. | $409.60 | 2019-2022 | |
| Abbvie INC. | $237.49 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $171.27 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $148.49 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $121.55 | 2019-2025 | |
| Genentech USA, INC. | $118.53 | 2023-2024 | Vabysmo |
| Ivantis, INC | $100.66 | 2019-2020 | |
| Horizon Therapeutics Plc | $96.58 | 2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $72.21 | 2019-2021 | |
| Astellas Pharma US INC | $64.70 | 2024 | Izervay |
| Glaukos Corporation | $64.52 | 2022 | |
| Amgen INC. | $53.08 | 2024-2025 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.12 | 2019 | |
| Sight Sciences, INC. | $24.88 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $22.87 | 2024 | Rayone Spheric, Omidria, Rayone Aspheric |
| New World Medical,INC. | $17.01 | 2023-2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Coopervision INC. | $17.00 | 2025 | Misight Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.